R Pg Family Wealth Advisory, LLC Abb Vie Inc. Transaction History

R Pg Family Wealth Advisory, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$163.84 - $199.33 $23,592 - $28,703	144 New	144 $28,000
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $18,441 - $23,444	-134 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $9,831 - $13,156	134 New	134 $13,000
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $22,995 - $29,393	-350 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $26,999 - $31,776	350 New	350 $0
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $27,113 - $32,081	-302 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $31,099 - $41,644	-338 Reduced 52.81%	302 $0
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $4,925 - $5,401	-55 Reduced 7.91%	640 $0
Q3 2017 Nov 08, 2017	SELL	$69.85 - $89.22 $5,029 - $6,423	-72 Reduced 9.39%	695 $0
Q2 2017 Aug 14, 2017	BUY	N/A	767	767 $0

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of R Pg Family Wealth Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on R Pg Family Wealth Advisory, LLC with notifications on news.